You have no items in your shopping cart.
Imaging endpoints are vital to your clinical trial’s success. ERT’s imaging technology harnesses the power of artificial intelligence and an expert team of scientists to make a significant difference in your study – not just tick a box on a protocol checklist.
ERT’s imaging management solutions platform ensures you’ll be able to easily access your data all in one place, whenever you want and provides 100% visibility into your data throughout the life of the trial.
Our AI technology guides radiologists to prioritize reads that need more scrutiny, increasing efficiency and reducing the risk of human error. This technology also enables real-time edit checks on data, so sites can avoid queries.
Access to multiple user profiles benefits busy study teams with the ability to quickly view or share the data that means the most to them.
ERT’s technology delivers the data objectivity, consistency and transparency you need to make better, faster decisions, and have confidence in your regulatory submissions.
Achieve database lock nearly 60% faster with ERT’s technology, which allows you to submit your imaging data to the appropriate regulatory body with the push of a button once all images have been evaluated.
Automatic workflow management, purpose-built around your study’s unique protocol and rules reduces the amount of site queries, eliminating burden on sites and improving satisfaction.
Use our technology to control video, image, and audio quality. We can help you avoid protocol deviation and reduce data queries.
By locating your data in a single platform, easily accessible throughout the course of your trial, you’re guaranteed to have an accurate audit trail for compliance and won’t have to cross-reference data from multiple systems.
Get confidence in your trial results by working with our team of imaging and regulatory experts, who have diverse experience that spans protocol management and widely-used disease response criteria.
Imaging in clinical trials has seen tremendous growth as evidenced by the number of trials initiated over the past two decades. Additionally, imaging data is increasingly used as the primary endpoint for some related trials. Put our expertise in drug, device and biologic imaging to work for you.